Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Calquence 100mg Capsules contain Acalabrutinib 100mg, a targeted anti-cancer medicine used to treat certain types of blood cancers. It belongs to a group of medicines called Bruton's Tyrosine Kinase (BTK) inhibitors. Instead of attacking all rapidly growing cells like traditional chemotherapy, Acalabrutinib works by blocking specific signals that help cancer cells grow and survive. This targeted approach helps slow the progression of the disease while reducing damage to many healthy cells. Calquence 100mg Capsules are supplied only on the prescription of a qualified oncologist or hematologist.
This medicine is commonly prescribed for adults diagnosed with certain B-cell blood cancers, particularly Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), and selected patients with Mantle Cell Lymphoma (MCL), depending on current treatment guidelines and the treating physician's clinical judgment. :contentReference[oaicite:0]{index=0}
Blood cancer cells rely on several internal signals to grow, divide, and avoid natural cell death. One of these important signals comes from a protein known as Bruton's Tyrosine Kinase (BTK).
Acalabrutinib blocks BTK, interrupting the communication pathway that cancer cells depend on. When these signals are blocked, the abnormal B-cells lose their ability to multiply efficiently and become less capable of surviving. Over time, this helps control the disease and reduce the number of cancer cells in the body. :contentReference[oaicite:1]{index=1}
Because Calquence is a targeted therapy, it works differently from conventional chemotherapy. Treatment response varies from one patient to another, and regular monitoring by the treating specialist is necessary throughout therapy.
Your doctor may prescribe Calquence for adults with specific blood cancers after carefully evaluating your medical condition, previous treatments, laboratory reports, and overall health.
CLL is one of the most common forms of leukemia in adults. It develops when abnormal lymphocytes accumulate in the blood, bone marrow, and lymph nodes. Calquence helps slow the growth of these abnormal cells and is used in several treatment settings according to approved prescribing information. :contentReference[oaicite:2]{index=2}
SLL is closely related to CLL but mainly affects the lymph nodes. Since both diseases involve similar abnormal B-cells, Acalabrutinib may be recommended by specialists as part of an individualized treatment plan where appropriate.
Mantle Cell Lymphoma is a rare and aggressive type of non-Hodgkin lymphoma. In selected adults, Calquence may be prescribed when considered appropriate by the treating oncologist based on current clinical recommendations and previous treatment history. :contentReference[oaicite:3]{index=3}
Calquence has become an important treatment option because it targets cancer cells more precisely than many older therapies. While treatment goals differ for every patient, potential clinical benefits may include:
Individual treatment outcomes depend on several factors, including the type of cancer, stage of disease, previous therapies, overall health, and how the body responds to treatment.
Calquence is intended for adult patients who have been diagnosed with eligible B-cell blood cancers by a qualified hematologist or oncologist. Before starting treatment, doctors usually review:
This medicine should never be started without professional medical advice. Regular follow-up appointments help doctors monitor how well the treatment is working and identify side effects early.
Before taking Calquence 100mg Capsules, tell your healthcare provider if you:
Your doctor may perform blood tests before treatment begins and continue monitoring throughout therapy to help ensure safe and effective use.
Depending on your diagnosis and treatment plan, your oncologist may also consider other targeted therapies or oncology medicines available on Welox Pharma. You can also browse the complete oncology medicine collection and manufacturer pages to explore related treatment options recommended by healthcare professionals.
Like all prescription medicines, Calquence 100mg (Acalabrutinib) can cause side effects. Not everyone experiences them, and many people are able to continue treatment with proper monitoring and supportive care. Your healthcare team will regularly assess your condition to help manage any unwanted effects during treatment.
Contact your doctor if you notice symptoms that are persistent, become severe, or cause concern.
Some of the more commonly reported side effects include:
Many of these side effects are manageable and may improve as your body adjusts to treatment. Never stop taking your medicine without discussing it with your oncologist.
Although less common, some reactions require urgent medical care. Seek immediate medical attention if you experience:
Because Acalabrutinib can affect the immune system and blood cells, your healthcare provider may recommend routine blood tests throughout treatment.
Before and during treatment, your doctor will carefully evaluate your overall health and monitor for possible complications. Following medical advice helps reduce the risk of serious side effects.
Calquence may increase the risk of bleeding. Inform your doctor if you are taking blood-thinning medicines, antiplatelet drugs, or herbal supplements that may increase bleeding risk. You should also inform your healthcare provider before any planned dental procedure or surgery.
Treatment may reduce your body's ability to fight infections. Contact your healthcare provider promptly if you develop:
Some patients receiving BTK inhibitors have developed irregular heart rhythms, including atrial fibrillation. Tell your doctor if you have a history of heart disease, palpitations, dizziness, or fainting episodes.
Patients receiving long-term treatment may have an increased risk of developing certain skin cancers or other new cancers. Your doctor may recommend regular skin examinations and advise you to protect your skin from excessive sunlight by wearing protective clothing and using sunscreen.
If you have existing liver disease or abnormal liver function tests, your doctor may monitor liver function more closely during treatment.
Calquence may not be suitable for everyone. Your doctor will decide whether it is appropriate based on your medical history and current health condition.
Inform your healthcare provider if you have:
Always provide your doctor with a complete list of your medical conditions before starting treatment.
Several medicines may affect how Calquence works or increase the likelihood of side effects. Always tell your healthcare provider about every medicine you take, including prescription medicines, over-the-counter drugs, vitamins, and herbal supplements.
Do not start, stop, or change any medicine without consulting your treating physician.
Take this medicine exactly as prescribed by your oncologist. Follow the instructions provided on your prescription label.
If you accidentally miss a dose, follow your doctor's instructions or the official prescribing guidance. Do not take extra capsules to make up for a missed dose unless specifically advised by your healthcare provider.
Regular medical follow-up is an important part of treatment with Calquence. Your healthcare team may schedule routine evaluations to monitor your response and overall health.
Monitoring may include:
Keeping all scheduled appointments allows your doctor to detect potential problems early and make treatment adjustments if necessary.
Calquence may harm an unborn baby. Women who are pregnant or planning to become pregnant should discuss the potential risks with their healthcare provider before starting treatment.
Effective contraception may be recommended during treatment and for a period after the last dose, according to your doctor's advice.
It is generally recommended to avoid breastfeeding while receiving Calquence because it is not known whether Acalabrutinib passes into breast milk.
Many patients treated for chronic lymphocytic leukemia and other B-cell cancers are older adults. Age alone does not determine whether Calquence is appropriate, but doctors may monitor older patients more closely because they can be more susceptible to infections, bleeding, and other treatment-related complications.
Seek medical advice promptly if you develop:
Early communication with your healthcare team can help manage side effects effectively and reduce the risk of serious complications.
Store Calquence 100mg (Acalabrutinib) Capsules according to the instructions provided on the product packaging or by your pharmacist. Proper storage helps maintain the quality and effectiveness of the medicine throughout its shelf life.
Your daily habits can play an important role in supporting your overall health during cancer treatment. While lifestyle changes cannot replace prescribed medicines, they may help you cope better with treatment.
Choose a healthy diet that includes fruits, vegetables, whole grains, lean proteins, and adequate fluids. If you experience nausea or loss of appetite, ask your healthcare provider or dietitian for nutritional advice.
Drinking enough water helps maintain normal body functions. Follow your doctor's advice if you have any medical condition that requires fluid restriction.
Since blood cancer treatments may weaken the immune system, simple precautions can help lower your risk of infection.
Because Calquence may increase bleeding risk, take extra care during daily activities.
No. Calquence contains Acalabrutinib, which is a targeted therapy known as a Bruton's Tyrosine Kinase (BTK) inhibitor. It works differently from traditional chemotherapy by targeting specific proteins involved in the growth of certain cancer cells.
The duration of treatment varies depending on the type of cancer, how well the medicine is working, and how well it is tolerated. Your oncologist will decide how long you should continue treatment.
Calquence is used to help control certain blood cancers and slow disease progression in eligible patients. Treatment goals differ for every individual, and your doctor can explain the expected outcomes based on your diagnosis.
No. Do not stop treatment without speaking to your healthcare provider. Stopping treatment on your own may affect disease control.
Some medicines can interact with Acalabrutinib. Always inform your doctor and pharmacist about all prescription medicines, over-the-counter products, vitamins, and herbal supplements you are taking.
Hair loss is not among the most commonly reported side effects of Calquence. However, every patient responds differently. Speak with your doctor if you notice any unexpected changes during treatment.
There is no specific recommendation for all patients, but alcohol may worsen certain side effects or interact with other medicines you are taking. Discuss alcohol consumption with your treating physician.
Follow your doctor's instructions. Do not take an extra capsule unless your healthcare provider specifically advises you to do so.
Yes. Your doctor will usually schedule routine blood tests to monitor blood cell counts, assess organ function, and evaluate your response to treatment.
Yes, many people treated with Calquence are older adults. Your healthcare provider will determine whether it is suitable based on your overall health and medical history.
Yes. Since the medicine can affect the immune system, patients may become more susceptible to infections. Promptly report fever, chills, persistent cough, or other signs of infection to your doctor.
Yes. Calquence 100mg Capsules are prescription-only medicines and should be used under the supervision of an experienced oncology specialist.
Patients exploring treatment options for blood cancers or other oncology conditions may also find these sections helpful on Welox Pharma:
Calquence 100mg Capsules should always be used exactly as prescribed by a qualified healthcare professional. Never change the dose, skip treatment, or stop taking the medicine without consulting your oncologist.
Regular follow-up appointments, laboratory monitoring, and open communication with your healthcare team are essential for achieving the best possible treatment outcomes while minimizing potential risks.
The information provided on this page is intended for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. Every patient is different, and treatment decisions should always be made by a qualified healthcare professional based on individual medical needs.
If you have questions about Calquence 100mg (Acalabrutinib) Capsules, consult your oncologist, hematologist, or pharmacist before starting or changing your treatment.
Treatment with Calquence 100mg (Acalabrutinib) requires regular follow-up appointments to evaluate how well the medicine is working and to identify any side effects at an early stage. Your healthcare provider may adjust your treatment plan based on your clinical response and laboratory results.
During treatment, your doctor may monitor:
Attend all scheduled appointments, even if you are feeling well. Regular monitoring helps your healthcare team manage treatment safely.
Before starting Calquence, it is helpful to have an open discussion with your cancer specialist. Consider asking:
You may also find these pages useful while learning about cancer treatment options:
The information on this page is provided for educational purposes only. It is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any questions about your medical condition or prescribed medicines.
Never start, stop, or change the dosage of Calquence 100mg (Acalabrutinib) Capsules without guidance from your treating physician. Treatment decisions should always be based on your individual medical history, current health status, and your specialist's clinical judgment.
Beside this well also export in other countries